NeuroBo Pharmaceuticals Inc (NASDAQ:NRBO) shares were down more than 6% at last check Wednesday. The Boston-based company announced preclinical data for its novel “G-Protein-Coupled Receptor 119 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results